Update οn the diagnosis and management of systemic lupus erythematosus

Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

(2020) John G Hanly et al.   ANNALS OF THE RHEUMATIC DISEASES

Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort

(2020) D Nikolopoulos et al.   LUPUS

Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or ‘blood-dominant’ lupus?

(2020) Antonis Fanouriakis et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study

(2020) Fang-Xiao Zhu et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

(2020) Antonis Fanouriakis et al.   ANNALS OF THE RHEUMATIC DISEASES

Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus

(2020) Konstantinos Tselios et al.   ANNALS OF THE RHEUMATIC DISEASES

Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis

(2020) Gabriella Moroni et al.   ANNALS OF THE RHEUMATIC DISEASES

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

(2020) Richard Furie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current challenges in the development of new treatments for lupus

(2019) Maria Dall'Era et al.   ANNALS OF THE RHEUMATIC DISEASES

Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity

(2019) Diogo Jesus et al.   ANNALS OF THE RHEUMATIC DISEASES

Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis

(2019) Murray B Urowitz et al.   ANNALS OF THE RHEUMATIC DISEASES

Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database

(2019) Laurent Arnaud et al.   ANNALS OF THE RHEUMATIC DISEASES

Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero

(2019) Johannes Mofors et al.   ANNALS OF THE RHEUMATIC DISEASES

Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes

(2019) Michelle Barraclough et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

(2019) Antonis Fanouriakis et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2019) Victoria Furer et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

(2019) Jing He et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

(2019) Martin Aringer et al.   Arthritis & Rheumatology

In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment

(2019) Christina Adamichou et al.   ANNALS OF THE RHEUMATIC DISEASES

Malignancies in systemic lupus erythematosus

(2019) Alexandra Ladouceur et al.   CURRENT OPINION IN RHEUMATOLOGY

Update on the pathogenesis of central nervous system lupus

(2019) Dionysis Nikolopoulos et al.   CURRENT OPINION IN RHEUMATOLOGY

New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion

(2019) Karim Sacre et al.   ANNALS OF THE RHEUMATIC DISEASES

Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren’s syndrome highlight T cell-initiated autoimmunity

(2019) Yukai Wang et al.   ANNALS OF THE RHEUMATIC DISEASES

Cardiovascular Disease in Systemic Lupus Erythematosus: recent data on epidemiology, risk factors and prevention

(2019) Myrto Kostopoulou et al.   Current Vascular Pharmacology

A Successful Trial for Lupus — How Good Is Good Enough?

(2019) Jane E. Salmon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

(2019) Eric F. Morand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis

(2018) Gabriella Moroni et al.   ANNALS OF THE RHEUMATIC DISEASES

Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE

(2018) David S Pisetsky et al.   ANNALS OF THE RHEUMATIC DISEASES

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies

(2018) Mimi Y Kim et al.   ANNALS OF THE RHEUMATIC DISEASES

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

(2018) Paul K. Whelton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

(2018) Daniel J Wallace et al.   LANCET

Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort

(2018) Constance Jensina Ulff-Møller et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus

(2018) Lea Winau et al.   ANNALS OF THE RHEUMATIC DISEASES

Two distinct clinical phenotypes of pulmonary arterial hypertension secondary to systemic lupus erythematosus

(2018) Fangfang Sun et al.   ANNALS OF THE RHEUMATIC DISEASES

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

The heart in systemic lupus erythematosus – A comprehensive approach by cardiovascular magnetic resonance tomography

(2018) Thilo Burkard et al.   PLoS One

Inflammation in SLE-PAH: good news or not?

(2018) Junyan Qian et al.   ANNALS OF THE RHEUMATIC DISEASES

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort

(2018) Arielle Mendel et al.   ANNALS OF THE RHEUMATIC DISEASES

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis

(2018) Brad H. Rovin et al.   KIDNEY INTERNATIONAL

Disease course patterns in systemic lupus erythematosus

(2018) K. Tselios et al.   LUPUS

Multitarget Therapy for Maintenance Treatment of Lupus Nephritis

(2017) Haitao Zhang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Antimalarial-induced cardiomyopathy: a systematic review of the literature

(2017) K Tselios et al.   LUPUS

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

(2016) L Andreoli et al.   ANNALS OF THE RHEUMATIC DISEASES

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

(2016) Ronald van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Clinical and financial burden of active lupus in Greece: a nationwide study

(2016) G Bertsias et al.   LUPUS

The global burden of SLE: prevalence, health disparities and socioeconomic impact

(2016) Erin E. Carter et al.   Nature Reviews Rheumatology

Distinguishing infectionsvsflares in patients with systemic lupus erythematosus: Table 1

(2016) Fabio E. Ospina et al.   RHEUMATOLOGY

Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement

(2016) Daniëlle Cohen et al.   RHEUMATOLOGY

Predictors of Pregnancy Outcomes in Patients With Lupus

(2015) Jill P. Buyon et al.   ANNALS OF INTERNAL MEDICINE

Multitarget Therapy for Induction Treatment of Lupus Nephritis

(2015) Zhihong Liu et al.   ANNALS OF INTERNAL MEDICINE

Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study

(2015) Chao-Han Lai et al.   ANNALS OF THE RHEUMATIC DISEASES

Prolonged remission in Caucasian patients with SLE: prevalence and outcomes

(2015) Margherita Zen et al.   ANNALS OF THE RHEUMATIC DISEASES

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)

(2015) Kate Franklyn et al.   ANNALS OF THE RHEUMATIC DISEASES

Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research

(2015) Jamal Mikdashi et al.   ARTHRITIS RESEARCH & THERAPY

Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families

(2015) Chang-Fu Kuo et al.   JAMA Internal Medicine

Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study

(2014) Seoyoung C Kim et al.   ANNALS OF THE RHEUMATIC DISEASES

Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus

(2014) Johanna T Gustafsson et al.   ANNALS OF THE RHEUMATIC DISEASES

Syndromes of Thrombotic Microangiopathy

(2014) James N. George et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus

(2014) Alessandra Bortoluzzi et al.   RHEUMATOLOGY

Lymphoma risk in systemic lupus: effects of disease activity versus treatment

(2013) Sasha Bernatsky et al.   ANNALS OF THE RHEUMATIC DISEASES

Diagnostic criteria for systemic lupus erythematosus: has the time come?

(2013) George K. Bertsias et al.   Nature Reviews Rheumatology

Annual direct medical cost of active systemic lupus erythematosus in five European countries

(2012) Andrea Doria et al.   ANNALS OF THE RHEUMATIC DISEASES

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade

(2010) G. K. Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES